|
1B07
CRK SH3 DOMAIN COMPLEXED WITH PEPTOID INHIBITOR
Deposited 1998-11-17
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
134–190(57 aa)
Fragment:SH3 DOMAIN
|
Not recorded
|
PYJ PHENYLETHANE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;29% PEG4000, 0.2 M AMMONIUM ACETATE, PH 6.0, pH 6.00
|
Resolution 2.50 Å
R-free 0.354
|
|
1CKA
STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
Deposited 1995-01-24
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
134–190(57 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.50 Å
|
|
1CKB
STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
Deposited 1995-01-24
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
134–190(57 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 1.90 Å
|
|
1JU5
Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
Deposited 2001-08-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
217–228(12 aa)
Fragment:Crk phosphopeptide
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate;Pressure ambient
NMR sample composition
0.6-1.5mM Crk SH2 domain U-15N, 13C; 50mM sodium phosphate pH6.8, 0.02% sodium azide | 90% H2O/10% D2O
|
Resolution not provided
|
|
1M30
Solution structure of N-terminal SH3 domain from oncogene protein c-Crk
Deposited 2002-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
134–191(58 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 134-191)
|
Mutation:R191G
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided
|
|
1M3A
Solution structure of a circular form of the truncated N-terminal SH3 domain from oncogene protein c-Crk.
Deposited 2002-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
135–191(57 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 135-191)
|
Mutation:R191G, E135C, deleted A134
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided
|
|
1M3B
Solution structure of a circular form of the N-terminal SH3 domain (A134C, E135G, R191G mutant) from oncogene protein c-Crk.
Deposited 2002-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
134–191(58 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 134-191)
|
Mutation:R191G, E135G, A134C
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided
|
|
1M3C
Solution structure of a circular form of the N-terminal SH3 domain (E132C, E133G, R191G mutant) from oncogene protein c-Crk
Deposited 2002-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
132–191(60 aa)
Fragment:N-TERMINAL SH3 DOMAIN (residues 132-191)
|
Mutation:R191G, added G133, C132
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;307 K;Ionic strength (raw mmCIF value) 100 mM NaCl;Pressure ambient
NMR sample composition
1mM SH3 NA, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM SH3 U-15N, 20mM sodium phosphate, 20 mM DTT-d10, 100 mM NaCl, 0.1% (w/v) NaN3 | 90% H2O/10% D2O
|
Resolution not provided
|
|
2GGR
Solution structure of the C-terminal SH3 domain of c-CrkII
Deposited 2006-03-24
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
230–304(75 aa)
Fragment:C-terminal Domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;298 K;Ionic strength (raw mmCIF value) 50mM;Pressure ambient
NMR sample composition
0.4 mM cSH3 domain U-15N,13C; 10mM phosphate buffer pH7.2; 50mM NaCl; 5mM DTT-d10; 0.1% NaN3; 1mM EDTA; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
5JN0
CRK-II SH2 domain
Deposited 2016-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
6–121(116 aa)
Fragment:UNP residues 6-121
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;297 K;100 mM MES pH 6.5, 12% PEG 20,000
|
Resolution 1.68 Å
R-free 0.210
|
|
5L23
Crystal structure of the complex between the N-terminal SH3 domain of CrkII and a proline-rich ligand
Deposited 2016-07-30
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
134–191(58 aa)
Fragment:UNP residues 134-191
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;286 K;Lithium sulfate monohydrate, PEG 3350
|
Resolution 1.77 Å
R-free 0.210
|